LEADER 01430nam 2200361Ia 450 001 996385278803316 005 20200824132358.0 035 $a(CKB)4940000000079061 035 $a(EEBO)2240977595 035 $a(OCoLC)ocm12798514e 035 $a(OCoLC)12798514 035 $a(EXLCZ)994940000000079061 100 $a19851115d1641 uy | 101 0 $aeng 135 $aurbn||||a|bb| 200 14$aThe charitable pestmaster, or, The cure of the plague$b[electronic resource] $econteining a few short and necessary instructions how to preserve the body from infection of the plagve as also to cure those that are infected : together with a little treatise concerning the cure of the small pox : published for the benefit of the poore of this city and not unmeet for the rich /$fby Thomas Shervvood .. 210 $aLondon $cPrinted by A.N. for John Francklin ...$d1641 215 $a[6], 13, [3] p 300 $aReproduction of original in Thomason Collection, British Library. 330 $aeebo-0158 606 $aSmallpox$zEngland$vEarly works to 1800 606 $aPlague$zEngland 615 0$aSmallpox 615 0$aPlague 700 $aSherwood$b Thomas$cPractitioner in physick.$01694 801 0$bEAA 801 1$bEAA 801 2$bUMI 801 2$bWaOLN 906 $aBOOK 912 $a996385278803316 996 $aThe charitable pestmaster, or, The cure of the plague$92351782 997 $aUNISA LEADER 01739nam a2200337 i 4500 001 991003188659707536 005 20020503184552.0 008 991229s1987 de ||| | ita 020 $a3533037673 020 $a3533039943 035 $ab10470086-39ule_inst 035 $aEXGIL116596$9ExL 040 $aDip.to Filol. Ling. e Lett.$bita 082 0 $a840.9 100 1 $aBuck, August$0152370 245 14$aDie italienische literatur im zeilalter Dantes und am ubergang vom mittelalter zur Renaissance /$cbanddirektor :$bAugust Buck 260 $aHeidelberg :$bCarl Winter,$c1987 300 $a2 v. ;$c25 cm. 490 0 $aGrundriss der romanischen literaturen des mittelalters ;$v10 500 $a10.1: Dantes Commedia und die Dante-rezeption des 14. und 15. Jahrhunderts. - Heidelberg : Carl Winter, 1987. - 285 p. ; 25 cm. 500 $a10.2: die italienische literatur im zeitalter Dantes und am literatur bis zur Renaissance. - Heidelberg : Carl Winter, 1987. - 375 p. ; 25 cm. 600 14$aAlighieri, Dante 650 4$aLetteratura italiana$ySec. 14.-15.$xStudi 907 $a.b10470086$b21-02-17$c27-06-02 912 $a991003188659707536 945 $aLE008 FL.M. (f.r.) IX 40/10/I$g1$i2008000005306$lle008$o-$pE0.00$q-$rl$s- $t0$u0$v0$w0$x0$y.i10543508$z27-06-02 945 $aLE008 FL.M. (f.r.) IX 40/10/II$g1$i2008000005450$lle008$o-$pE0.00$q-$rl$s- $t0$u0$v0$w0$x0$y.i1054351x$z27-06-02 945 $aLE008 FL.M. (f.r.) IX 40/10/I bis$g1$i2008000005467$lle008$o-$pE0.00$q-$rl$s- $t0$u0$v0$w0$x0$y.i10543521$z27-06-02 996 $aItalienische literatur im zeilalter Dantes und am ubergang vom mittelalter zur Renaissance$9222635 997 $aUNISALENTO 998 $ale008$b01-01-99$cm$da $e-$fita$gde $h4$i3 LEADER 03969nam 2201117z- 450 001 9910566478403321 005 20220506 035 $a(CKB)5680000000037596 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/81147 035 $a(oapen)doab81147 035 $a(EXLCZ)995680000000037596 100 $a20202205d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aAtherosclerosis$eTechnologies of Personalized Medicine 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 online resource (150 p.) 311 08$a3-0365-3528-4 311 08$a3-0365-3527-6 330 $aThe first national conference with international participation, "Fundamental aspects of atherosclerosis: scientific research for improving the technologies of personalized medicine", was held in Novosibirsk on 15 October, 2021. The purpose of this conference was to disseminate the latest basic and clinical findings in the fields of etiology, clinical characteristics, and modern diagnostics and treatments of atherosclerosis among various relevant specialists. The conference was intended for practicing cardiologists, primary care physicians, medical geneticists, and physician-scientists. The conference included plenary sessions, specialty sessions, satellite symposia, an open competition for young scientists. 517 $aAtherosclerosis 606 $aCardiovascular medicine$2bicssc 606 $aMedicine and Nursing$2bicssc 610 $aABCG5 610 $aacute coronary syndrome 610 $aadiponectin 610 $aaging 610 $aantiplatelet 610 $aAPOB 610 $aAPOC3 610 $aarterial hypertension 610 $aaspirin 610 $aatherosclerosis 610 $aatrial fibrillation 610 $acalcification 610 $acatalase 610 $acirculating biochemical markers 610 $acoronary atherosclerosis 610 $acoronary atherosclerosis presence and severity 610 $acoronary heart disease 610 $aCox regression analysis 610 $acumulative LDL-C level 610 $adeterminants 610 $adiabetes mellitus 610 $aDNA methylation 610 $aepicardial adipose tissue 610 $aepigenetic age 610 $afamilial hypercholesterolemia 610 $aglutathione peroxidase 610 $aHAPIEE project 610 $aHAPIEE study 610 $aimmune cells blood count 610 $aintegrated biomarker (i-BIO) 610 $ainterleukin-6 610 $aischemic heart disease 610 $aLDLR 610 $aleptin 610 $alight transmission aggregometry 610 $alipoprotein(a) 610 $aLPL 610 $ametalloproteinases 610 $amonounsaturated fatty acids 610 $amultiplex assay 610 $amultiplex ligation-dependent probe amplification 610 $amyocardial infarction 610 $an/a 610 $anested case-control 610 $anon-sensitivity 610 $aobesity 610 $aoxidative stress 610 $aperivascular adipose tissue 610 $aPlateletworks® 610 $apolyunsaturated fatty acids 610 $apopulation 610 $aprevalence 610 $aprognosis 610 $arare variants 610 $aresistance 610 $aRussian population cohort 610 $asaturated fatty acids 610 $aSREBF1 610 $asuperoxide dismutase 610 $atargeted sequencing technologies 610 $avalidation 610 $avisual markers 615 7$aCardiovascular medicine 615 7$aMedicine and Nursing 700 $aRagino$b Yuliya I$4edt$01308060 702 $aRagino$b Yuliya I$4oth 906 $aBOOK 912 $a9910566478403321 996 $aAtherosclerosis$93029089 997 $aUNINA